UBS analyst Matthew Weston downgraded Sanofi (SAN:FP) (NASDAQ: SNY) from Buy to Neutral with a price target of EUR88.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE